Related references
Note: Only part of the references are listed.T-cell help dependence of memory CD8+ T-cell expansion upon vaccinia virus challenge relies on CD40 signaling
Gregor Bedenikovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses
Hyun-Il Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Clinical implications of co-inhibitory molecule expression in the tumor microenvironment for DC vaccination: a game of stop and go
Angela Vasaturo et al.
FRONTIERS IN IMMUNOLOGY (2013)
Dendritic cells in cancer immunotherapy clinical trials: are we making progress?
Lisa H. Butterfield
FRONTIERS IN IMMUNOLOGY (2013)
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
Michael Hoelzel et al.
NATURE REVIEWS CANCER (2013)
A Potent Vaccination Strategy That Circumvents Lymphodepletion for Effective Antitumor Adoptive T-cell Therapy
Hyun-Il Cho et al.
CANCER RESEARCH (2012)
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Suzanne L. Topalian et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
Fabian Benencia et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
Jennifer Landsberg et al.
NATURE (2012)
The role of interleukin-2 during homeostasis and activation of the immune system
Onur Boyman et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
W. Joost Lesterhuis et al.
CLINICAL CANCER RESEARCH (2011)
Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
Katjana Klages et al.
CANCER RESEARCH (2010)
Efficient Treg depletion induces T-cell infiltration and rejection of large tumors
Xingrui Li et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Immune Therapy for Cancer
Michael Dougan et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
Weiqing Jing et al.
BLOOD (2009)
Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects
Hyun-Il Cho et al.
CANCER RESEARCH (2009)
In vivo Expansion, Persistence, and Function of Peptide Vaccine-Induced CD8 T Cells Occur Independently of CD4 T Cells
Deepak Assudani et al.
CANCER RESEARCH (2008)
Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection
Sang-Jun Ha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Comparative methodologies of regulatory T cell depletion in a murine melanoma model
Norimasa Matsushita et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Generation of CD8 T cell memory is regulated by IL-12
Erika L. Pearce et al.
JOURNAL OF IMMUNOLOGY (2007)
Manipulating the rate of memory CD8+ T cell generation after acute infection
Vladimir P. Badovinac et al.
JOURNAL OF IMMUNOLOGY (2007)
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
Ruth R. French et al.
BLOOD (2007)
CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help
Maria Genevive H. Hernandez et al.
JOURNAL OF IMMUNOLOGY (2007)
In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate:: A candidate antigen for treating prostate cancer
Maria de la Luz Garcia-Hernandez et al.
CANCER RESEARCH (2007)
Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer
T Lin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Optimization of a self antigen for presentation of multiple epitopes in cancer immunity
JA Guevara-Patiño et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Selective stimulation of T cell subsets with antibody-cytokine immune complexes
O Boyman et al.
SCIENCE (2006)
CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts
AT den Boer et al.
CANCER RESEARCH (2005)
Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination
VP Badovinac et al.
NATURE MEDICINE (2005)
Jump-starting the immune system: prime-boosting comes of age
DL Woodland
TRENDS IN IMMUNOLOGY (2004)
CD8+ T cell contraction is controlled by early inflammation
VP Badovinac et al.
NATURE IMMUNOLOGY (2004)
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control
DW Mullins et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen
JS Gold et al.
JOURNAL OF IMMUNOLOGY (2003)
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population
MJ Estcourt et al.
INTERNATIONAL IMMUNOLOGY (2002)
The prime-boost strategy: exciting prospects for improved vaccination
IA Ramshaw et al.
IMMUNOLOGY TODAY (2000)